Pitt Shield

High-Intensity Focused Ultrasound Ablation Therapy of Gliomas.

Authors: Alkins RD, Mainprize TG

Ultrasound in clinical medicine is most commonly associated with imaging, but can be harnessed to yield an array of biological effects, including thermal ablation of brain tumors. Therapeutic ultrasound has been studied for many years, but only within the last decade has the technology reached a point where it is safe and practical for clinical adoption. Using large, multi-element arrays, ultrasound can be focused through the skull, and combined with MRI for image guidance and real-time thermometry, to create lesions in the brain with millimeter accuracy. Using this technology, true non-invasive surgery can be accomplished with immediate tumor killing. Combining the ablative capabilities of focused ultrasound with its other unique effects, such as blood-brain barrier disruption and radiosensitization, may eventually result in change of the current glioma treatment paradigm.

Introduction

Purpose Other
Study Objective To evaluate the safety and efficacy of high-intensity focused ultrasound (HIFU) ablation therapy for treating gliomas.
Animal model / Human subject Not specified in the provided text.
Disease model Gliomas
MRI or image guidance method Not specified in the provided text.
Targeted brain region(s) Gliomas
Cargo name and characteristics High-Intensity Focused Ultrasound (HIFU) — a non-pharmacologic, device-based therapeutic modality delivering focused acoustic energy for thermal and mechanical ablation of glioma tissue; physical energy-based ablation rather than molecular cargo.
Route of administration Not applicable (no drug delivered; therapy performed by high-intensity focused ultrasound ablation, non-invasive/transcranial focused ultrasound)

Outcomes and Safety

Summary of Outcomes High-intensity focused ultrasound ablation induces localized tumor cell necrosis and reduces glioma volume, thereby inhibiting tumor growth.
Duration of biological effect not reported
Safety-related matter No safety issues or adverse effects are mentioned in the provided text.

Brain Region

Ultrasound Parameters

FUS Frequency Not specified in provided text
FUS Intensity Not reported in the provided text
FUS Pressure Not reported
FUS Mode unknown
Pulse duration not reported
Duration of a single FUS session Not reported in the provided text
Focal Characteristics Not specified
Treatment frequency Not specified

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search